ArticleBlood2024

Sequential antigen loss and branching evolution in lymphoma after CD19- and CD20-targeted T-cell-redirecting therapy.

Johannes Duell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.